drugset / Trial / NCT00027053
Trazodone for Sleep Disturbance in Early Alcohol Recovery
Phase 2
Completed
173 enrolled
Rhode Island Hospital
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an inpatient detoxification program. Subjects will undergo a baseline assessment and random assignment to trazodone or identical placebo for 12 weeks. All persons completing the alcohol detoxification at Stanley Street Treatment and Resources (SSTAR) will be screened. (SSTAR of Rhode Island provides detoxification services to non/underinsured persons of Rhode Island.)
Timeline
- Start
- 2002-06
- Primary completion
- 2006-01
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trazodone | Small molecule | 50 mg | — |
| Subject | Trazodone | Small molecule | 150 mg | — |